Instrument Inactif

Communiqués Lexaria Corp Other OTC

Actions

US52886N2080

Produits pharmaceutiques

Cours en clôture Other OTC
- ^USD	-

13/08	Lexaria Bioscience Corp. conclut un accord de transfert de matériel avec Pegbio Co., Ltd	CI
13/07	Lexaria Bioscience Corp. publie ses résultats pour le troisième trimestre et les neuf mois clos le 31 mai 2026	CI

Communiqués

13/08	Lexaria Enters a Material Transfer Agreement With PegBio	AQ
30/07	Lexaria Announces Effective Date for Reverse Stock Split	AQ
06/07	Lexaria Updates Business Development	AQ
25/06	Lexaria's Human Study GLP-1-H26-7 Has Begun Dosing on Schedule	AQ
23/06	Lexaria's Animal Study GLP-1-A26-1 Has Begun Dosing on Schedule	AQ
17/06	GLP-1 "Arms Race" Intensifies as the Addressable Markets Continue to Expand	AQ
17/06	GLP-1 'Arms Race' Intensifies as the Addressable Markets Continue to Expand	AQ
09/06	Lexaria's Animal Study Examining Next-Generation GLP-1 drugs is Underway.	AQ
09/06	Lexaria's Animal Study Examining Next-Generation GLP-1 drugs is Underway	AQ
03/06	Lexaria Attending the BIO International Convention, as Part of a Broader Business Development Program	AQ
19/05	Lexaria Receives Independent Review Board Approval to Begin Human Pilot Study #7	AQ
19/05	Lexaria Receives Independent Review Board Approval to Begin Human Pilot Study #7	AQ
07/05	Lexaria Bioscience Releases Second Episode of Investor Video Series	AQ
07/05	Lexaria Bioscience Releases Second Episode of Investor Video Series	AQ
05/05	Lexaria Updates Progress on Human Study #7	AQ
05/05	Lexaria Updates Progress on Human Study #7	AQ
01/05	Lexaria Bioscience Launches Ongoing Investor Video Series to Expand Shareholder Communications	AQ
29/04	Material Transfer Agreement Between Pharmaceutical Company and Lexaria is Extended	AQ
23/04	Lexaria Launches New Study to Examine Next-Generation GLP-1 Drugs	AQ
23/04	Lexaria Launches New Study to Examine Next-Generation GLP-1 Drugs	AQ
21/04	Lexaria Expects Oral GLP-1 Pills to Generate Billions in New Industry Sales	AQ
21/04	Lexaria Expects Oral GLP-1 Pills to Generate Billions in New Industry Sales	AQ
15/04	Lexaria's New Animal Study Aims to Expand Valuable Intellectual Property	AQ
07/04	Lexaria Applauds Eli Lilly's Foundayo(TM) Drug Approval	AQ
01/04	Lexaria to Begin New Human Clinical Study in GLP-1	AQ